For the NHS
For business
About Us
Get in touch

Dr Nigel Pitchford

Senior Leadership Team
The Board

Nigel is ieso’s Chief Executive Officer and his in-depth understanding of the investment network brings substantial fundraising, strategic and operational experience to the company.

He has been CEO since March 2019 but has had a close association with ieso since 2013. It was then that – with Nigel was their Chief Investment Officer and group board director – Touchstone Innovations plc led the first institutional investment round into ieso.

A Big Data pioneer of sorts, his doctoral work in computational chemistry contributed to the discipline we would now call data science – coincidentally a key aspect of ieso’s unique approach to mental healthcare.

It was Nigel’s MBA at the Warwick Business School that first opened his eyes to the prospects of venture capital. A field that was just beginning to excel at bringing cutting-edge science to market.

Nigel specialised in life sciences and during his two-decade venture capital career has been influential in nurturing such successful companies as Domantis, Arakis, Apatech, Horizon Discovery and Oxford Immunotec.

“When investing in biotech, you can spend your whole career working with companies who never actually sell a product or touch a patient outside of a clinical trial setting. Whereas in the digital health arena – and with ieso in particular – we touch on people's lives every day and the feedback mechanism is immediate. You can see that you're doing something worthwhile and tangible, and truly making an impact. That's become really important to me.”

Dr Nigel Pitchford

Chief Executive Officer

Dr Valentin Tablan

Chief Artificial Intelligence Officer

Dr Andy Blackwell

Group Chief Science & Strategy Officer

Dr Andy Blackwell

Group Chief Science & Strategy Officer

Stephen Freer

EVP Clinical

Dr Charlotte Housden

Chief Operating Officer

Michael Black

Chief Financial Officer

Dani Smallbone

Chief Marketing Officer

Kate Woolland

Chief Partnerships Officer

James Kellerman

Chief Technology Officer

Dr Valentin Tablan

Chief Artificial Intelligence Officer

Dr Jennifer Gentile

SVP US Clinical Operations

Lynn Lakey

Interim Managing Director

Chris Kightley

Interim Managing Director

Dr Andrew Welchman

Executive Vice President for Impact

Danah Tangen

Chief of Staff